Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-02Clinical Trial Update: Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial of CG0070 for high-grade non-muscle invasive bladder cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-03-17Clinical Trial Update: A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy [Phase 3]
Relmada Therapeutics has withdrawn its Phase 3 trial of NDV-01 administered intravesically for BCG-unresponsive non-muscle invasive bladder …
-
CLINICAL_TRIALS withdrawal · 2026-03-17Clinical Trial Update: A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT [Phase 3]
A Phase 3 trial evaluating NDV-01 (sustained-release gemcitabine-docetaxel) for intermediate-risk non-muscle invasive bladder cancer followi…
-
CLINICAL_TRIALS withdrawal · 2025-06-16Clinical Trial Update: A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]
Phase 1 study evaluating Eciskafusp Alfa in combination with Bacillus Calmette-Guérin for BCG-unresponsive high-risk Non-muscle Invasive Bla…
-
CLINICAL_TRIALS withdrawal · 2015-09-01Clinical Trial Update: A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) [NA]
Clinical trial update indicates that a prospective open-label dose-ranging study of pre-TURBT intravesical mitomycin C mixed with TC-3 Gel f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-08-29Clinical Trial Update: First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC [Phase 3]
A Phase 3 trial comparing EN3348 (MCC) with BCG for non-muscle invasive bladder cancer has been withdrawn.